Search research articles
Contact Us
Filters
Showing results (61-70 of 244) with videos related to
Page
of 25
Sort By:
Cell Cycle (Georgetown, Tex.)
|
May 15, 2012
Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis
Tamara Ratovitski, Ekaterine Chighladze, Nicolas Arbez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 17, 2011
Age, CAG repeat length, and clinical progression in Huntington's disease
Adam Rosenblatt, Brahma V Kumar, Alisa Mo, et al.
Nature Neuroscience
|
September 19, 2006
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W Smith, Zhong Pei, Haibing Jiang, et al.
Journal of Neuroscience Research
|
November 30, 2018
Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI
Lin Chen, Jun Hua, Christopher A Ross, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 7, 2009
Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion"
Jason Brandt, Anjeli B Inscore, Julianna Ward, et al.
Acta Neuropathologica
|
March 22, 2002
Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders
Koichi Wakabayashi, Simone Engelender, Yuji Tanaka, et al.
Neuroimage
|
February 16, 2011
Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
Yong Cheng, Qi Peng, Zhipeng Hou, et al.
Annals of Neurology
|
March 28, 2007
Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci
Dobrila D Rudnicki, Susan E Holmes, Mark W Lin, et al.
Neuroscience Research
|
September 13, 2006
Primate disrupted-in-schizophrenia-1 (DISC1): high divergence of a gene for major mental illnesses in recent evolutionary history
Lyuda Bord, Jeff Wheeler, Matthew Paek, et al.
Journal of Neurochemistry
|
February 5, 2013
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
Jing Jin, Jennifer Albertz, Zhihong Guo, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 244) with videos related to
Sort By:
Page
of 25
Cell Cycle (Georgetown, Tex.)
|
May 15, 2012
Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis
Tamara Ratovitski, Ekaterine Chighladze, Nicolas Arbez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 17, 2011
Age, CAG repeat length, and clinical progression in Huntington's disease
Adam Rosenblatt, Brahma V Kumar, Alisa Mo, et al.
Nature Neuroscience
|
September 19, 2006
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W Smith, Zhong Pei, Haibing Jiang, et al.
Journal of Neuroscience Research
|
November 30, 2018
Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI
Lin Chen, Jun Hua, Christopher A Ross, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 7, 2009
Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion"
Jason Brandt, Anjeli B Inscore, Julianna Ward, et al.
Acta Neuropathologica
|
March 22, 2002
Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders
Koichi Wakabayashi, Simone Engelender, Yuji Tanaka, et al.
Neuroimage
|
February 16, 2011
Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
Yong Cheng, Qi Peng, Zhipeng Hou, et al.
Annals of Neurology
|
March 28, 2007
Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci
Dobrila D Rudnicki, Susan E Holmes, Mark W Lin, et al.
Neuroscience Research
|
September 13, 2006
Primate disrupted-in-schizophrenia-1 (DISC1): high divergence of a gene for major mental illnesses in recent evolutionary history
Lyuda Bord, Jeff Wheeler, Matthew Paek, et al.
Journal of Neurochemistry
|
February 5, 2013
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
Jing Jin, Jennifer Albertz, Zhihong Guo, et al.
Page
of 25